In this study, a nanocomposite based on copper oxide-zinc oxide nanoparticles and Gum Arabic (GA@CuO-ZnO nanocomposite) was successfully synthesized using green method. Characterization results revealed that the prepared nanocomposite appeared at the nanoscale level, showed excellent dispersion, and formed stable colloidal nano-solutions. The bimetallic GA@CuO-ZnO nanocomposite was evaluated for its anticancer, antibacterial, and antifungal properties. Cytotoxicity testing of the synthesized GA@CuO-ZnO nanocomposite against Wi38 and Vero normal cell lines showed IC₅₀ values of 143.3 and 220.9 μg ml⁻¹, respectively, indicating that the nanocomposite is safe for use. Moreover, the synthesized GA@CuO-ZnO nanocomposite showed anticancer activity against HepG2 and MCF7 cell lines, with IC₅₀ values of 54.7 and 79.2 μg ml⁻¹, respectively. The nanocomposite also showed promising antibacterial activity against Escherichia coli, Salmonella typhimurium, Staphylococcus aureus, S. epidermis, and Bacillus subtilis, with MIC values ranging from 31.25 to 62.5 μg ml⁻¹. Furthermore, the prepared nanocomposite exhibited antifungal activity against Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus and A. brasiliensis, with an MIC of 31.25 μg ml⁻¹ against all tested fungal strains, except A. fumigatus (MIC 125 μg ml⁻¹). In conclusion, the synthesized GA@CuO-ZnO nanocomposite was successfully synthesized, and it exhibited promising antibacterial, antifungal and anticancer activities at safe doses.
No takes yet. Share an insight, caveat, or question.
El‐Sayyad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: